Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiae

References

• Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519–531.
   PubMed Web of Science ®Google Scholar
• Denning DW, Marinus A, Cohen J, . An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998; 37: 173–180.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366.
   PubMed Web of Science ®Google Scholar
• Segal BH. Aspergillosis. N Engl J Med 2009; 360: 1870–1884.
   PubMed Web of Science ®Google Scholar
• Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 2010; 18: 195–204.
   PubMed Web of Science ®Google Scholar
• Howard SJ, Cerar D, Anderson MJ, . Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068–1076.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009; 12: 789–795.
   Google Scholar
• Gomez-Lopez A, Garcia-Effron G, Mellado E, . In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2003; 47: 3085–3088.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, . Epidemiological cut-offs and cross resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 2008; 52: 2468–2472.
   PubMed Web of Science ®Google Scholar
• Mellado E, Garcia-Effron G, Buitrago MJ, . Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 2005; 49: 2536–2538.
   PubMed Web of Science ®Google Scholar
• Howard SJ, Webster I, Moore CB, . Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 28: 450–453.
   PubMed Web of Science ®Google Scholar
• Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodriguez-Tudela JL. A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2003; 47: 1120–1124.
   PubMed Web of Science ®Google Scholar
• Mellado, E, Garcia-Effron G., Alcazar-Fuoli L, . Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob. Agents Chemother 2004; 48: 2747–2750.
   PubMed Web of Science ®Google Scholar
• Mellado E, Garcia-Effron G, Alcazar-Fuoli L, . A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51: 1897–1904.
   PubMed Web of Science ®Google Scholar
• Bellí G, Garí E, Aldea M, Herrero E. Functional analysis of yeast essential genes using a promoter-substitution cassette and the tetracycline-regulatable dual expression system. Yeast 1998; 14: 1127–1138.
   PubMed Web of Science ®Google Scholar
• Yen K, Gitsham P, Wishart J, Oliver SG, Zhang N. An improved tetO promoter replacement system for regulating the expression of yeast Genes. Yeast 2003; 20: 1255–1262.
   PubMed Web of Science ®Google Scholar
• Longtine MS, McKenzie A, Demarini D J 3rd, . Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 1998 ; 14: 953–961.
   PubMed Web of Science ®Google Scholar
• Alcazar-Fuoli L, Mellado E, Garcia-Effron G, . Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility. Antimicrob Agents Chemother 2006; 50: 453–460.
   PubMed Web of Science ®Google Scholar
• Coste AT, Ramsdale M, Ischer F, Sanglard D. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. Microbiology 2008; 154: 1491–1501.
   PubMed Web of Science ®Google Scholar
• de Micheli M, Bille J, Schueller C, Sanglard D. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 2002; 43: 1197–1214.
   PubMed Web of Science ®Google Scholar
• Snelders E, van der Lee HA, Kuijpers J, . Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219.
   PubMed Web of Science ®Google Scholar
• Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, . Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol 2001; 39: 2431–2438.
   PubMed Web of Science ®Google Scholar
• Mann PA, Parmegiani RM, Wei SQ, . Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14-α demethylase. Antimicrob Agents Chemother 2003: 47: 577–581.
   PubMed Web of Science ®Google Scholar
• Nascimento AM, Goldman GH, Park S, . Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother 2003; 47: 1719–1726.
   PubMed Web of Science ®Google Scholar
• Cools HJ, Parker JE, Kelly DE, . Heterologous expression of mutated eburicol 14-demethylase (CYP51) proteins of Mycosphaerella graminicola demonstrates effects on azole fungicide sensitivity and intrinsic protein function. Appl Environ Microbiol 2010; 76: 2866–2872.
   PubMed Web of Science ®Google Scholar
• Xiao L, Madison V, Chau AS, . Three-dimensional models of wild-type and mutated forms of cytochrome P450 14a-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother 2004; 48: 568–574.
   PubMed Web of Science ®Google Scholar
• Sheng Ch, Zhang W, Zhang M, . Homology modeling of lanosterol 14α-demethylase of Candida albicans and Aspergillus fumigatus: an insight into the enzyme-substrate interactions. J Biomol Struct Dyn 2004; 22: 91–99.
   PubMed Web of Science ®Google Scholar
• Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modelling. Antimicrob Agents Chemother 2010; 54: 2425–2430.
   PubMed Web of Science ®Google Scholar
• Mavridou E, Brüggemann RJ, Melchers WJ, Mouton JW, Verweij PE. Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. Antimicrob Agents Chemother 2010; 54: 860–865.
   PubMed Web of Science ®Google Scholar